
Volv Global logo

Volv Global model flags early ARDS risk in pneumonia: developed on US claims, validated on external ICU data and against independent clinical review, results will be presented at ERS Congress 2026.

Volv Global model flags early ARDS risk in pneumonia: developed on US claims, validated on external ICU data and against independent clinical review, results will be presented at ERS Congress 2026.
Developed on US claims, validated on external ICU data and against independent clinical review, results will be presented at ERS Congress 2026.
Our methodology is built to recognise disease-specific patterns in RWD regardless of disease. ARDS is one proof point; the same approach applies wherever a disease has a distinct signature in the data”— Vahid Esmaeili, Data Science and Digital Health Director at Volv Global
ÉPALINGES, SWITZERLAND, August 28, 2026 /EINPresswire.com/ -- In brief
● In retrospective analysis, the model flagged patients likely to progress from community-acquired pneumonia (CAP) to ARDS up to five days before diagnosis.